New vaccine trains immune system to fight multiple cancers
Disease control
Completed
This study tested a cancer vaccine called ETBX-011 in 43 people with advanced cancers (colorectal, lung, breast, or prostate) that make a protein called CEA. The vaccine uses a modified virus to teach the immune system to attack cancer cells. The main goals were to check safety a…
Phase: PHASE1, PHASE2 • Sponsor: NantCell, Inc. • Aim: Disease control
Last updated May 16, 2026 23:51 UTC